Date published: 2025-10-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ox40L Antibody (OX89): sc-53105

2.0(1)
Write a reviewAsk a question

Datasheets
  • Ox40L Antibody (OX89) is a rat monoclonal IgG1, cited in 1 publications, provided at 200 µg/ml
  • raised against rat and mouse CD4 and mouse CD134 ligand Chimaeric protein
  • Ox40L Antibody (OX89) is recommended for detection of Ox40L of mouse origin by FCM
  • Anti-Ox40L Antibody (OX89) is available conjugated to agarose for IP; HRP for WB, IHC(P) and ELISA; and to either phycoerythrin or FITC for IF, IHC(P) and FCM
  • also available conjugated to Alexa Fluor® 488, Alexa Fluor® 546, Alexa Fluor® 594 or Alexa Fluor® 647 for WB (RGB), IF, IHC(P) and FCM, and for use with RGB fluorescent imaging systems, such as iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
  • also available conjugated to Alexa Fluor® 680 or Alexa Fluor® 790 for WB (NIR), IF and FCM; for use with Near-Infrared (NIR) detection systems, such as LI-COR®Odyssey®, iBright™ FL1000, FluorChem™, Typhoon, Azure and other comparable systems
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for Ox40L Antibody (OX89). This work is in progress.

QUICK LINKS

SEE ALSO...

Ox40L Antibody (OX89) is a rat monoclonal IgG1 antibody that detects Ox40L of mouse origin by flow cytometry (FCM). Ox40L (OX89) antibody is available in both non-conjugated and various conjugated forms, including agarose, horseradish peroxidase (HRP), phycoerythrin (PE), fluorescein isothiocyanate (FITC), and multiple Alexa Fluor® conjugates, providing versatility for different experimental needs. The Ox40 ligand, also known as gp34, is a type II membrane protein characterized by its lack of signal peptide, which is crucial for function in immune responses. As a member of the tumor necrosis factor (TNF) superfamily, Ox40L serves as a vital costimulatory molecule that facilitates interactions between dendritic cells and T cells, as well as promoting T cell homing and B cell activation. The engagement of Ox40L with Ox40 provides a potent costimulatory signal to effector T cells, significantly enhancing activation and proliferation. Notably, Ox40L is predominantly expressed on activated B cells, while Ox40 is found on activated T cells, underscoring the importance of this interaction in regulating antigen-specific T cell responses in vivo. This dynamic is particularly critical during both the priming and effector phases of T cell activation, where Ox40L is expressed on antigen-presenting cells (APCs), thereby playing a key role in orchestrating effective immune responses.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

Ox40L Antibody (OX89) References:

  1. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.  |  Ishii, N., et al. 2010. Adv Immunol. 105: 63-98. PMID: 20510730
  2. OX40/OX40 ligand interactions in T-cell regulation and asthma.  |  Kaur, D. and Brightling, C. 2012. Chest. 141: 494-499. PMID: 22315115
  3. Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome.  |  Kawana, Y., et al. 2021. Int J Mol Sci. 22: PMID: 34830466
  4. OX40 Ligand-Mannose-Binding Lectin Fusion Protein Induces Potent OX40 Cosignaling in CD4+ T Cells.  |  Sato, A., et al. 2022. Biol Pharm Bull. 45: 1798-1804. PMID: 36450532
  5. Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial.  |  Weidinger, S., et al. 2023. Br J Dermatol. 189: 531-539. PMID: 37463508
  6. OX40/OX40 ligand and its role in precision immune oncology.  |  Thapa, B., et al. 2024. Cancer Metastasis Rev. 43: 1001-1013. PMID: 38526805
  7. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis.  |  Guttman-Yassky, E., et al. 2024. Br J Dermatol. 191: 488-496. PMID: 38836560
  8. Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis.  |  Weidinger, S., et al. 2024. J Allergy Clin Immunol.. PMID: 39522654
  9. Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes.  |  Sato, A., et al. 2024. Front Immunol. 15: 1473815. PMID: 39867912
  10. OX40 ligand promotes follicular helper T cell differentiation and development in mice with immune thrombocytopenia.  |  Yang, Z., et al. 2025. J Zhejiang Univ Sci B. 26: 240-253. PMID: 40082203

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Ox40L Antibody (OX89)

sc-53105
200 µg/ml
$316.00

Ox40L Antibody (OX89) AC

sc-53105 AC
500 µg/ml, 25% agarose
$416.00

Ox40L Antibody (OX89) HRP

sc-53105 HRP
200 µg/ml
$316.00

Ox40L Antibody (OX89) FITC

sc-53105 FITC
200 µg/ml
$330.00

Ox40L Antibody (OX89) PE

sc-53105 PE
200 µg/ml
$343.00

Ox40L Antibody (OX89) Alexa Fluor® 488

sc-53105 AF488
200 µg/ml
$357.00

Ox40L Antibody (OX89) Alexa Fluor® 546

sc-53105 AF546
200 µg/ml
$357.00

Ox40L Antibody (OX89) Alexa Fluor® 594

sc-53105 AF594
200 µg/ml
$357.00

Ox40L Antibody (OX89) Alexa Fluor® 647

sc-53105 AF647
200 µg/ml
$357.00

Ox40L Antibody (OX89) Alexa Fluor® 680

sc-53105 AF680
200 µg/ml
$357.00

Ox40L Antibody (OX89) Alexa Fluor® 790

sc-53105 AF790
200 µg/ml
$357.00